These facts are updated till 13 Dec 2023, and are based on Volza's Peru Import dataPeru Import data of Lansoprazole sourced from 70 countries export import shipments with names of buyers, suppliers, top Decision maker's contact information like Direct, phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
3003901000 | LANSOPRAZOLE, S/M, S/M|BATCH : LAN/P/2/2015060071|MFG DATE: 06/2015, EXP DATE: 05/2018|LANSOPRAZOLE PELLET 8.5% W/W|USP | India | Peru | 30 | |||
2933399000 | LANSOPRAZOL USP S/M|POLVO SECO|USO REACTIVO PATRON DE REFERENCIA PARA ANALISIS QUIMICO DE MATERIA PRIMA|USP RS X 150 MG | India | Peru | 1 | |||
3004902900 | LAN-30, 30MG // LAN // S/M|LOTE: S04379; MFG 04/2015; EXP 03/2017|MEDICAMENTOS PARA USO HUMANO|500X5X10C//CAPSULAS|LAN-30, 30MG // LANSOPRAZOLE DELAYED RELEASE CAPSULES USP 30C//500X5X10C | India | Peru | 500 | |||
3004902900 | MEDICAMENTO S/M S/M|LANSOPRAZOL|MEDICAMENTO GENERICO DE USO HUMANO|CAJA X 28 CAPSULAS|REF.142445. LANSOPRAZOL 30MG CAP. LOTE: 3149412 VCTO 08/2017 | Colombia | Peru | 936 | |||
3004902900 | CAPSULAS DE LIBERACION RETARDADA,GENFAR,S/M,|PRODUCTO FARMACEUTICO|USO:MEDICAMENTO PARA USO HUMANO|CJA X 7 CAP // LOTE: 5GC7526E VCTO: 30.09.2017|LANSOPRAZOL 30MG CJX7 CAP-PE (498089),N¦PARTE: VR15139 | Colombia | Peru | 4619 | 60 More Columns Available | ||
3822009000 | ESTANDARES DE CALIBRACION, USP, S/M|PYRIDYL)METHYL)SULFONYL)BENZIMIDAZOLE|LOT# H0I193, ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A, 25MG (2-(((3-METHYL-4-(2,2,2,-TRIFLUOROETHOXY)-2-|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | MEDICAMENTO S/M S/M|LANSOPRAZOL|MEDICAMENTO GENERICO DE USO HUMANO|CAJA X 28 CAPSULAS|REF.142445. LANSOPRAZOL 30MG CAP. LOTE:3157268,3159152, VCTO:12/201702/2018 | Colombia | Peru | 702 | |||
3004902900 | LAN-30, 30MG // LAN // S/M|LOTE: T03407, MFG: 03/2016, EXP: 02/2018|MEDICAMENTOS PARA USO HUMANO|403X5X10C//CAPSULAS|LAN-30, 30MG // LANSOPRAZOLE DELAYED-RELEASE CAPSULES USP 30MG//403X5X10C | India | Peru | 403 | |||
3003901000 | LANSOPRAZOLE PELLETS 8.5%, S/M, S/M|04 TAMBORES DE 50.00 KGS C/U|PRODUCTO SEMI-ELABORADO PARA USO FARMACEUTICO|LOTE NO. FO21E601|MFG DATE : 05-2016 ; EXP DATE : 04-2019 | India | Peru | 200 | |||
3004902900 | MEDICAMENTO S/M S/M|LANSOPRAZOL|MEDICAMENTO GENERICO DE USO HUMANO|CAJA X 28 CAPSULAS|REF.142445. LANSOPRAZOL 30MG CAP. LOTE:3149412, VCTO:08/2017 | Colombia | Peru | 1404 | |||
2933999090 | LANSOPRAZOLE, S/M, S/M|(2-(((3-METHYL-4-(2,2,)|USO : PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE RELATED COMPOUND A (25 MG)|1356927,MATERIA PRIMA ESTANDARES | United States | Peru | 1 | |||
3004902900 | LANSOPRAZOL, S/M, S/M|LOTE:7GC0031A F.EXP:11.2018,PRESENTACION:CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG|PAN00498089 | Colombia | Peru | 3381 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO / PRODUCTO: FARMACEUTICO|LOTE NO. 8GC3079D F. EXP. 06/2020|PRESENTACION: CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 6912 | |||
3822003000 | LANSOPRAZOLE RELATED COMPOUND, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2-(((3-METHYL-4-(2,2,)|1356927 | India | Peru | 1 | |||
2933399000 | LANSOPRAZOLE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE (150 MG)|1356916 | India | Peru | 2 | |||
3003901000 | LANSOPRAZOL, S/M, S/M|LOTE: LAPC033121, FECHA DE VTO: 01/11/2020|PRODUCTO SEMITERMINADO DE USO HUMANO|LANSOPRAZOL PELLETS AL 8.5%|90003114 | India | Peru | 180 | |||
3003901000 | LANSOPRAZOL, S/M, S/M|LOTE: LAPC0500318, VENC.: 01.01.2021|PRODUCTO SEMITERMINADO DE USO HUMANO|LANSOPRAZOL PELLETS AL 8.5%|90003114 | India | Peru | 180 | |||
2933399000 | LANSOPRAZOLE RELATED COMPOUND, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2-(((3-METHYL-4-(2,2,|1356927 | India | Peru | 2 | |||
2933399000 | LANSOPRAZOLE RELATED COMPOUND, USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1356927|(2-(((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDYL)METHYL)SULFONYL)BENZIMIDAZOLE),131926-9 | India | Peru | 1 | |||
3822003000 | LANSOPRAZOLE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2-(((3-METHYL-4-(2,2,|1356927 | India | Peru | 2 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|PRESENTACION:CAJA X 7 CAPSULAS|LOTE:7GC4882A - F.EXP:09/2019; MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS|PAN00498089,MEDIO DE PAGO: TRANSFERENCIA BANCARIA | Colombia | Peru | 3456 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO // FARMACEUTICO|LOTE: 8GC4280A // F. EXPIRA.: 01/09/2020.|LANSOPRAZOL 30MG|CODIGO: PAN00498089 | Colombia | Peru | 5446 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO|LOTE: 8GC3079D; F. EXPIRA.: 01/06/2020|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS, PRESENTACION: CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 6912 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|LOTE:8GC4280AF.EXPIRA 09/2020.|MEDICAMENTOS PARA USO HUMANO|PRESENT.CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 551 | |||
2933399000 | LANSOPRAZOL, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOL (150 MG)|1356916 | India | Peru | 2 | |||
3004902900 | PRAZOLEX 30 MG, SIEGFRIED, S/M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS CON MICROGRANULOS GASTRORRESISTENTES, 000002044808, LOTE: 00511, VENCE: 31/08/202|LANSOPRAZOL 30MG | Argentina | Peru | 3388 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|CAJA X 7 CAPSULAS|LOTE: 9GC2580E-F.EXPIRA: 05.2021|LANSOPRAZOL 30MG CJX7 CAP-PE|PAN00743292 | Colombia | Peru | 734 | |||
3004902900 | LAN-30, 30MG // LAN // S/M|LOTE: Y12763, Y12765//MFG: 02/2019, 04/2019//EXP: 01/2022, 03/2022|MEDICAMENTOS PARA USO HUMANO|151X5X10C//CAPSULAS|LAN-30, 30MG // LANSOPRAZOLE DELAYED-RELEASE CAPSULES USP 30MG//151X5X10C | India | Peru | 151 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO|LOTE: 9GC0925F; F.EXP: 01/2021|PRESENTACION: CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 3456 | |||
2933399000 | LANSOPRAZOL PELLETS 8.5%, S/M, S/M|BATCH N¦ LANS850880719|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS - 8.5%|MFG DATE: JULY/2019 - EXP DATE: JUNE/2022 | India | Peru | 500 | |||
2933399000 | LANSOPRAZOLE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE (150 MG)|1356916 | India | Peru | 14 | |||
3003901000 | LANSOPRAZOL, S/M, S/M|LOTE: LAPC0430120, FECHA DE VTO: 31/12/2022|PRODUCTO SEMITERMINADO DE USO HUMANO|LANSOPRAZOLE PELLETS AL 8.5%-NOSCH LABS|90003114 | India | Peru | 125 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: LOT#F2J371 , PRES: 25MG|ITEM NUMBER: 1356931|LANSOPRAZOLE RELATED COMPOUND B|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | LAN-30 LAN S/M|PRESENTACION: 5X10C|MEDICAMENTO PARA USO HUMANO. PROTECTOR GASTRICO|LOTE N¦ M2012310, MFD: 06/2020, EXP.DATE: 05/2023|LAN-30 (LANSOPRAZOLE USP 30MG) | India | Peru | 192 | |||
2933399000 | LANSOPRAZOLE, SIGMA ALDRICH, S/M|PHR1390-1G, BATCH: LRAC3483|REACTIVOS PARA LABORATORIO, S-NTESIS DE SUSTANCIAS, 1 X 1G|ESTANDAR DE LANSOPRAZOL | United States | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|ITEM: 1356927|REACTIVO PARA PRUEBA DE LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A, 25MG|LOT # R07130 | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|LOTE: A03210A, EXP.: 10.2022|MEDICAMENTO PARA USO HUMANO // PRODUCTO: FARMACEUTICO|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS|PAN00743292 | Colombia | Peru | 3234 | |||
2933399000 | LANSOPRAZOLE , SIGMA ALDRICH , S-M|PHR1390-1G , BATCH: LRAC3483|REACTIVOS PARA LABORATORIO , S-NTESIS DE SUSTANCIAS|ESTANDAR DE LANSOPRAZOL | United States | Peru | 2 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT# R07130 , PRES: 25MG|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A | India | Peru | 1 | |||
2933399000 | LANSOPRAZOLE PELLETS 8.5%, S-M, S-M|PHARMACEUTICAL RAW MATERIAL|25 KG X 3 HDPE DRUMS = 75KG - PRINCIPIO ACTIVO PARA LA FABRICACION DE TABLETAS|LANSOPRAZOLE PELLETS 8.5% W-W|LOTE:LAN-P-2-2021010003, F.M:DEC 2020 , F.EXP:NOV 2023 - | India | Peru | 75 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH: LANS851441220 , MFG. DATE: NOV-2020 , EXP. DATE: OCT-2023|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5% W-W|EN 8 TAMBORES CON 25KG C-U | India | Peru | 200 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH N¦ LANS850080421 - MFG. DATE: MAR-2021; EXP. DATE: FEB-2024|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5%|EN 20 TAMBORES DE 25 KGS C-U 2933199000 HSN | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL , TEVA , S-M|LOTE:111427|F-V:30-06-2022|15MG. FRASCO X 30 CAPSULAS | Israel | Peru | 1296 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R07130, PRES: 25MG|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A | India | Peru | 1 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00542 , VENCE: 30-06-2023|LANSOPRAZOL 30MG HS 3004902900 | Argentina | Peru | 3572 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - RS EN PROCE DE REINSCRIPCION EXP: 19024951|MEDICAMENTO PARA USO HUMANO - LOTE: B00965A F.EXP.: 4.2023|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 | Colombia | Peru | 7344 | |||
3003901000 | LANSOPRAZOLE PELLETS 8.5%W-W S-M S-M|LANSOPRAZOLE PELLETS 8.5%W-W|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|20 TAMBORES DE 25 KG NET C-U|LOTE:LANS850170621 MFG DATE:06-2021 EXP DATE:05-2024 | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - PRINCIPIO:LANSOPRAZOL|USO: MEDICAMENTO PARA USO HUMANO - LOTE: C02405A F. EXPIRA:4.2024|LANSOPRAZOL 30MG CAPCR BL7 M24 PE-LANSOPRAZOL 30MG|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 4934 | |||
30049099 | CAPSULES >> LANSOPRAZOLE-30mg CAPSULES Batch No.CLZ-140105 MANUFACTURING :01-2014 Exp:12-2016 | India | Peru | 10656 | |||
30049034 | LANSOPRAZOLE >> PHARMA DRG.& MED.LAN 30CON:LANSOPRAZOLEUSP 30 MGPACK:898X5X10C ; 30CON:LANSOPRAZOLE USP | India | Peru | 898 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|PRESENT.:CAJA X 7 CAPSULAS - PRODUCTO FARMACEUTICO|USO: MEDICAMENTO PARA USO HUMANO - PRINCIPIO:LANSOPRAZOL|LANSOPRAZOL 30MG CJX7 CAP-PE|743292 - GP15139 - LOTE:D01493A VCTO:12-2024 - REGISTRO SANITARIO:EE-00699 | Colombia | Peru | 6299 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|USO: MEDICAMENTO PARA USO HUMANO|LOTE:D01284D F.VCTO:11-2024|LANSOPRAZOL 30MG CJX7 CAP-PE - PRESENTACION: CAJA X 7 CAPSULAS|743292 - GP15139 | Colombia | Peru | 5238 | |||
2933399000 | LANSOPRAZOLE , SIGMA ALDRICH , S-M|PHR1390-1G|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 1G|ESTANDAR DE LANSOPRAZOL , BATCH: LRAD2346 | China | Peru | 1 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00586 , VENCE: 30-04-2025|LANSOPRAZOL 30MG | Argentina | Peru | 7951 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R07130|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A (25MG) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|BATCH: D556 - MFG.DT. 04.2023 - EXP.DT. 10.2025|MEDICAMENTO DE USO HUMANO|LANSOPRAZOL 30MG - LANSOPRAZOL|LANSOPRAZOL 30MG CAPSULA BLANDA DE LIBERACION RETARDADA - CAJA *10 , TRANSFRENCIA BANCARIA N | India | Peru | 5200 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS LOTE: D00772D F. EXPIRA.09-2024|MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG CJX7 CAP-PE|743292- GP15139- REGISTRO SANITARIO: EE-00699 | Colombia | Peru | 4982 | |||
30049099 | LANSOPRAZOL 30MG LANSOPRAZOLE CAPSULES30MG B/NO.D556, M/DT.04/2023,E/DT.10/20255200X10X10 | India | Peru | 5200 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - PRINCIPIO:LANSOPRAZOL|USO: MEDICAMENTO PARA USO HUMANO - LOTE: D00470C F. EXPIRA:07.2024|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS|743292 , GP15139 - RS: EE-00699 DEL 06-08-2019 - 06-08-2024 | Colombia | Peru | 10453 | |||
2933399000 | LANSOPRAZOLE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1356916|LANSOPRAZOLE (150 MG) | India | Peru | 3 | |||
2933199000 | LANSOPRAZOLE PELLETS , S-M , S-M|LANSOPRAZOLE PELLETS ¿ 8.5% W-W 20 HDPE DRUMS (25 KGS NET EACH ) |EN LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS|BATCH N° : LANS850601122-FECHA MANUFACTURA:NOVIEMBRE 2022-FECHA EXPIRACION: OCTUBRE 2025 | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - PRINCIPIO:LANSOPRAZOL|USO: MEDICAMENTO PARA USO HUMANO - LOTE: C02531A F. EXPIRA:05.2024|LANSOPRAZOL 30MG CAPCR BL7 M24 PE-LANSOPRAZOL 30MG|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 4921 | |||
2933399000 | LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|LANSOPRAZOL COMPUESTO RELACIONADO A (25 MG) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00334-SP|CAT: 1356927 , LOTE: R07130 | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R14880|ITEM: 1356916|LANSOPRAZOLE (150 MG) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R07130|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ( ( (3-METHYL-4 (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDIL) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH: LANS850591122 , MFG. DATE: NOV-2022; EXP. DATE: OCT-2025|IMSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5% W-W|EN 20 DRUMS CON 25KGS C-U | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS -LOTE:C01991A F.V:3.2024|MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 4956 | |||
2933399000 | LANSOPRAZOLE , SIGMA ALDRICH , S-M|PHR1390-1G|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 2 X 1G|ESTANDAR DE LANSOPRAZOL , BATCH: LRAD0184 | China | Peru | 2 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00572 , VENCE: 30-09-2024|LANSOPRAZOL 30MG | Argentina | Peru | 9955 | |||
3004902900 | LANSOPRAZOL 15 MG , S-M , S-M|ANTIULCEROSO - CONCENTRACION: 15 MG. - FORMA FARMACEUTICA: CAPSULAS|DONACION|FRASCO X 30 CAPSULAS. CAJA X 47 FRASCOS - CODIGO:422483|LOTE: 3137240 - FECHA DE VENCIMIENTO: 31-05-2023 | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 15 MG , S-M , S-M|ANTIULCEROSO - CONCENTRACION: 15 MG. - FORMA FARMACEUTICA: CAPSULAS|DONACION|FRASCO X 30 CAPSULAS. CAJA X 48 FRASCOS - CODIGO:422366|LOTE: 3137240 - FECHA DE VENCIMIENTO: 31-05-2023 | India | Peru | 5 | |||
3004902900 | LAN-30 LAN S-M|LOTE: M2205670 , MFG: 02-2022 , EXP: 01-2025 , LOTE: M2206964 , MFG: 04-2022 , EXP: 03-2025|INHIBIDOR DE LA BOMBA DE PROTONES - PROTECTOR GASTRICO - MEDICAMENTOS PARA USO HUMANO|3980 X 5 X 10 C|LANSOPRAZOL 30MG CAPSULA DE LIBERACION RETARDADA | India | Peru | 3980 | |||
2933399000 | LANSOPRAZOLE RELATED , SIGMA ALDRICH , S-M|PHR3019-50MG|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 50MG|COMPOUND A , BATCH: LRAC7161|N OPERACIÓN: 28269983 | China | Peru | 1 | |||
2933399000 | LANSOPRAZOLE RELATED , SIGMA ALDRICH , S-M|PHR3019-50MG|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 50MG|COMPOUND A , BATCH: LRAC7161|N OPERACIÓN: 28270350 | China | Peru | 1 | |||
2933399000 | LANSOPRAZOLE RELATED , SIGMA ALDRICH , S-M|PHR3019-50MG|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 50MG|COMPOUND A , BATCH: LRAC7161|N OPERACIÓN: 28269997 | China | Peru | 1 | |||
3004902900 | HELIGO (KIT PARA H. PILORI) HELIGO S-M|ANTIINFECCIOSO DE HELICOBACTER PILORI|MEDICAMENTO DE USO HUMANO|LANSOPRAZOL 30MG - TINIDAZOL 500MG - CLARITROMICINA 250 MG TABLETA|LOTE: M2211639 , MFG: 04-2022 , EXP: 03-2025 | India | Peru | 1748 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO- LOTE: C01437A 01-2024|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 3833 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO- LOTE: C01170A 12-2023|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 3552 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R07130|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ( ( (3-METHYL-4 (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDIL) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 30 MG TABLETA , MYLAN , S-M|CAJA X 18 PAQUETES - CONCENTRACION: 30 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420906|LOTE: 3132608 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 36 | |||
3004902900 | LANSOPRAZOL 30 MG TABLETA , MYLAN , S-M|CAJA X 18 PAQUETES - CONCENTRACION: 30 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420907|LOTE: 3132607 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 36 | |||
3004902900 | LANSOPRAZOL 15 MG TABLETA , MYLAN , S-M|CAJA X 2 PAQUETES - CONCENTRACION: 15 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420765|LOTE: 3132605 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 1 | |||
3004902900 | LANSOPRAZOL 15 MG TABLETA , MYLAN , S-M|CAJA X 48 PAQUETES - CONCENTRACION: 15 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420761|LOTE: 3132605 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 8 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH: LANS850260622 , MFG. DATE: JUNE-2022; EXP. DATE: MAY-2025|IMSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5% W-W|EN 40 DRUMS CON 25 KGS C-U | India | Peru | 1000 | |||
3003901000 | LANSOPRAZOL PELLETS S-M S-M|LOTE LAN-P-2-2022020036 , FEC. FAB 02-2022 - F. EXP. 01-2025|REACTIVO DE REFERENCIA PARA ANALISIS DE INSUMOS FARMACEUTICOS|LANZOPRAZOL|LANSOPRAZOL PELLETS | India | Peru | 100 | |||
30049034 | PHRMA DRG&MED:LAN-30 LANSOPRAZOLE DELYED | India | Peru | 199000 | |||
3822900000 | LANSOPRAZOL COMPUESTO RELACIONADO A , U.S PHARMACOPEIAL , S-M|LANSOPRAZOL COMPUESTO RELACIONADO A (VIAL X 25 MG) |EST¦NDAR DE REFERENCIA CERTIFICADOS PARA PRUEBAS DE LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) |CONTROL DE CALIDAD | India | Peru | 1 | |||
2933399000 | LANSOPRAZOL COMPUESTO RELACIONADO B , USP , S-M|LANSOPRAZOL COMPUESTO RELACIONADO B (25 MG) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00335-SP|1356931 | China | Peru | 2 | |||
2933399000 | LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|LANSOPRAZOL COMPUESTO RELACIONADO A (25 MG) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00334-SP|1356927 | India | Peru | 2 | |||
2933199000 | LANSOPRAZOL PELLETS 8.5% S-M S-M|LANSOPRAZOLE PELLETS 8.5% 20 DRUMS|INSUMOS PARA INDUSTRIA FARMACEUTICA|LOTE: LANS850100322 MFG:03-2022 EXP:02-2025|LANSOPRAZOL PELLETS 8.5% | India | Peru | 500 | |||
2933199000 | LANSOPRAZOL PELLETS 8.5% S-M S-M|LANSOPRAZOLE PELLETS 8.5% 3 DRUMS|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|LOTE: LANS850100322 MFG:03-2022 EXP: 02-2025|LANSOPRAZOL PELLETS 8.5% | India | Peru | 75 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO- LOTE: C00771C F.EXP.: 10.2023|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 3703 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO -RS: EE- 00699|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 , LOTE: C00624C F.EXP.: 09.2023 | Colombia | Peru | 8672 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO -RS: EE- 00699|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 , LOTE: C00624C F.EXP.: 09.2023 | Colombia | Peru | 8672 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00559 , VENCE: 30-04-2024|LANSOPRAZOL 30MG | Argentina | Peru | 10151 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00559 , VENCE: 30-04-2024|LANSOPRAZOL 30MG | Argentina | Peru | 10151 | |||
2933399000 | LANSOPRAZOL PELLETS 8.5% , S-M , S-M|BATCH N° LANS850040222|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5%|MFG DATE: FEB-2022 - EXP DATE: JAN-2025 | India | Peru | 150 | |||
2933399000 | LANSOPRAZOL PELLETS 8.5% , S-M , S-M|BATCH N° LANS850040222|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5%|MFG DATE: FEB-2022 - EXP DATE: JAN-2025 | India | Peru | 150 | |||
3822900000 | E1 LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|E1 LANSOPRAZOL COMPUESTO RELACIONADO A|AN-LISIS QU-MICO.|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ({[3-METHYL-4- (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDYL|1356927 | India | Peru | 25 | |||
3822900000 | E1 LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|E1 LANSOPRAZOL COMPUESTO RELACIONADO A|AN-LISIS QU-MICO.|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ({[3-METHYL-4- (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDYL|1356927 | India | Peru | 25 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
3003901000 | LANSOPRAZOLE, S/M, S/M|BATCH : LAN/P/2/2015060071|MFG DATE: 06/2015, EXP DATE: 05/2018|LANSOPRAZOLE PELLET 8.5% W/W|USP | India | Peru | 30 | |||
2933399000 | LANSOPRAZOL USP S/M|POLVO SECO|USO REACTIVO PATRON DE REFERENCIA PARA ANALISIS QUIMICO DE MATERIA PRIMA|USP RS X 150 MG | India | Peru | 1 | |||
3004902900 | LAN-30, 30MG // LAN // S/M|LOTE: S04379; MFG 04/2015; EXP 03/2017|MEDICAMENTOS PARA USO HUMANO|500X5X10C//CAPSULAS|LAN-30, 30MG // LANSOPRAZOLE DELAYED RELEASE CAPSULES USP 30C//500X5X10C | India | Peru | 500 | |||
3004902900 | MEDICAMENTO S/M S/M|LANSOPRAZOL|MEDICAMENTO GENERICO DE USO HUMANO|CAJA X 28 CAPSULAS|REF.142445. LANSOPRAZOL 30MG CAP. LOTE: 3149412 VCTO 08/2017 | Colombia | Peru | 936 | |||
3004902900 | CAPSULAS DE LIBERACION RETARDADA,GENFAR,S/M,|PRODUCTO FARMACEUTICO|USO:MEDICAMENTO PARA USO HUMANO|CJA X 7 CAP // LOTE: 5GC7526E VCTO: 30.09.2017|LANSOPRAZOL 30MG CJX7 CAP-PE (498089),N¦PARTE: VR15139 | Colombia | Peru | 4619 | 60 More Columns Available | ||
3822009000 | ESTANDARES DE CALIBRACION, USP, S/M|PYRIDYL)METHYL)SULFONYL)BENZIMIDAZOLE|LOT# H0I193, ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A, 25MG (2-(((3-METHYL-4-(2,2,2,-TRIFLUOROETHOXY)-2-|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | MEDICAMENTO S/M S/M|LANSOPRAZOL|MEDICAMENTO GENERICO DE USO HUMANO|CAJA X 28 CAPSULAS|REF.142445. LANSOPRAZOL 30MG CAP. LOTE:3157268,3159152, VCTO:12/201702/2018 | Colombia | Peru | 702 | |||
3004902900 | LAN-30, 30MG // LAN // S/M|LOTE: T03407, MFG: 03/2016, EXP: 02/2018|MEDICAMENTOS PARA USO HUMANO|403X5X10C//CAPSULAS|LAN-30, 30MG // LANSOPRAZOLE DELAYED-RELEASE CAPSULES USP 30MG//403X5X10C | India | Peru | 403 | |||
3003901000 | LANSOPRAZOLE PELLETS 8.5%, S/M, S/M|04 TAMBORES DE 50.00 KGS C/U|PRODUCTO SEMI-ELABORADO PARA USO FARMACEUTICO|LOTE NO. FO21E601|MFG DATE : 05-2016 ; EXP DATE : 04-2019 | India | Peru | 200 | |||
3004902900 | MEDICAMENTO S/M S/M|LANSOPRAZOL|MEDICAMENTO GENERICO DE USO HUMANO|CAJA X 28 CAPSULAS|REF.142445. LANSOPRAZOL 30MG CAP. LOTE:3149412, VCTO:08/2017 | Colombia | Peru | 1404 | |||
2933999090 | LANSOPRAZOLE, S/M, S/M|(2-(((3-METHYL-4-(2,2,)|USO : PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE RELATED COMPOUND A (25 MG)|1356927,MATERIA PRIMA ESTANDARES | United States | Peru | 1 | |||
3004902900 | LANSOPRAZOL, S/M, S/M|LOTE:7GC0031A F.EXP:11.2018,PRESENTACION:CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG|PAN00498089 | Colombia | Peru | 3381 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO / PRODUCTO: FARMACEUTICO|LOTE NO. 8GC3079D F. EXP. 06/2020|PRESENTACION: CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 6912 | |||
3822003000 | LANSOPRAZOLE RELATED COMPOUND, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2-(((3-METHYL-4-(2,2,)|1356927 | India | Peru | 1 | |||
2933399000 | LANSOPRAZOLE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE (150 MG)|1356916 | India | Peru | 2 | |||
3003901000 | LANSOPRAZOL, S/M, S/M|LOTE: LAPC033121, FECHA DE VTO: 01/11/2020|PRODUCTO SEMITERMINADO DE USO HUMANO|LANSOPRAZOL PELLETS AL 8.5%|90003114 | India | Peru | 180 | |||
3003901000 | LANSOPRAZOL, S/M, S/M|LOTE: LAPC0500318, VENC.: 01.01.2021|PRODUCTO SEMITERMINADO DE USO HUMANO|LANSOPRAZOL PELLETS AL 8.5%|90003114 | India | Peru | 180 | |||
2933399000 | LANSOPRAZOLE RELATED COMPOUND, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2-(((3-METHYL-4-(2,2,|1356927 | India | Peru | 2 | |||
2933399000 | LANSOPRAZOLE RELATED COMPOUND, USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1356927|(2-(((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDYL)METHYL)SULFONYL)BENZIMIDAZOLE),131926-9 | India | Peru | 1 | |||
3822003000 | LANSOPRAZOLE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2-(((3-METHYL-4-(2,2,|1356927 | India | Peru | 2 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|PRESENTACION:CAJA X 7 CAPSULAS|LOTE:7GC4882A - F.EXP:09/2019; MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS|PAN00498089,MEDIO DE PAGO: TRANSFERENCIA BANCARIA | Colombia | Peru | 3456 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO // FARMACEUTICO|LOTE: 8GC4280A // F. EXPIRA.: 01/09/2020.|LANSOPRAZOL 30MG|CODIGO: PAN00498089 | Colombia | Peru | 5446 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO|LOTE: 8GC3079D; F. EXPIRA.: 01/06/2020|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS, PRESENTACION: CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 6912 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|LOTE:8GC4280AF.EXPIRA 09/2020.|MEDICAMENTOS PARA USO HUMANO|PRESENT.CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 551 | |||
2933399000 | LANSOPRAZOL, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOL (150 MG)|1356916 | India | Peru | 2 | |||
3004902900 | PRAZOLEX 30 MG, SIEGFRIED, S/M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS CON MICROGRANULOS GASTRORRESISTENTES, 000002044808, LOTE: 00511, VENCE: 31/08/202|LANSOPRAZOL 30MG | Argentina | Peru | 3388 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|CAJA X 7 CAPSULAS|LOTE: 9GC2580E-F.EXPIRA: 05.2021|LANSOPRAZOL 30MG CJX7 CAP-PE|PAN00743292 | Colombia | Peru | 734 | |||
3004902900 | LAN-30, 30MG // LAN // S/M|LOTE: Y12763, Y12765//MFG: 02/2019, 04/2019//EXP: 01/2022, 03/2022|MEDICAMENTOS PARA USO HUMANO|151X5X10C//CAPSULAS|LAN-30, 30MG // LANSOPRAZOLE DELAYED-RELEASE CAPSULES USP 30MG//151X5X10C | India | Peru | 151 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|MEDICAMENTO PARA USO HUMANO|LOTE: 9GC0925F; F.EXP: 01/2021|PRESENTACION: CAJA X 7 CAPSULAS|PAN00498089 | Colombia | Peru | 3456 | |||
2933399000 | LANSOPRAZOL PELLETS 8.5%, S/M, S/M|BATCH N¦ LANS850880719|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS - 8.5%|MFG DATE: JULY/2019 - EXP DATE: JUNE/2022 | India | Peru | 500 | |||
2933399000 | LANSOPRAZOLE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|LANSOPRAZOLE (150 MG)|1356916 | India | Peru | 14 | |||
3003901000 | LANSOPRAZOL, S/M, S/M|LOTE: LAPC0430120, FECHA DE VTO: 31/12/2022|PRODUCTO SEMITERMINADO DE USO HUMANO|LANSOPRAZOLE PELLETS AL 8.5%-NOSCH LABS|90003114 | India | Peru | 125 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: LOT#F2J371 , PRES: 25MG|ITEM NUMBER: 1356931|LANSOPRAZOLE RELATED COMPOUND B|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | LAN-30 LAN S/M|PRESENTACION: 5X10C|MEDICAMENTO PARA USO HUMANO. PROTECTOR GASTRICO|LOTE N¦ M2012310, MFD: 06/2020, EXP.DATE: 05/2023|LAN-30 (LANSOPRAZOLE USP 30MG) | India | Peru | 192 | |||
2933399000 | LANSOPRAZOLE, SIGMA ALDRICH, S/M|PHR1390-1G, BATCH: LRAC3483|REACTIVOS PARA LABORATORIO, S-NTESIS DE SUSTANCIAS, 1 X 1G|ESTANDAR DE LANSOPRAZOL | United States | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|ITEM: 1356927|REACTIVO PARA PRUEBA DE LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A, 25MG|LOT # R07130 | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 30MG, S/M, S/M|LOTE: A03210A, EXP.: 10.2022|MEDICAMENTO PARA USO HUMANO // PRODUCTO: FARMACEUTICO|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS|PAN00743292 | Colombia | Peru | 3234 | |||
2933399000 | LANSOPRAZOLE , SIGMA ALDRICH , S-M|PHR1390-1G , BATCH: LRAC3483|REACTIVOS PARA LABORATORIO , S-NTESIS DE SUSTANCIAS|ESTANDAR DE LANSOPRAZOL | United States | Peru | 2 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT# R07130 , PRES: 25MG|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A | India | Peru | 1 | |||
2933399000 | LANSOPRAZOLE PELLETS 8.5%, S-M, S-M|PHARMACEUTICAL RAW MATERIAL|25 KG X 3 HDPE DRUMS = 75KG - PRINCIPIO ACTIVO PARA LA FABRICACION DE TABLETAS|LANSOPRAZOLE PELLETS 8.5% W-W|LOTE:LAN-P-2-2021010003, F.M:DEC 2020 , F.EXP:NOV 2023 - | India | Peru | 75 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH: LANS851441220 , MFG. DATE: NOV-2020 , EXP. DATE: OCT-2023|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5% W-W|EN 8 TAMBORES CON 25KG C-U | India | Peru | 200 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH N¦ LANS850080421 - MFG. DATE: MAR-2021; EXP. DATE: FEB-2024|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5%|EN 20 TAMBORES DE 25 KGS C-U 2933199000 HSN | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL , TEVA , S-M|LOTE:111427|F-V:30-06-2022|15MG. FRASCO X 30 CAPSULAS | Israel | Peru | 1296 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R07130, PRES: 25MG|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A | India | Peru | 1 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00542 , VENCE: 30-06-2023|LANSOPRAZOL 30MG HS 3004902900 | Argentina | Peru | 3572 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - RS EN PROCE DE REINSCRIPCION EXP: 19024951|MEDICAMENTO PARA USO HUMANO - LOTE: B00965A F.EXP.: 4.2023|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 | Colombia | Peru | 7344 | |||
3003901000 | LANSOPRAZOLE PELLETS 8.5%W-W S-M S-M|LANSOPRAZOLE PELLETS 8.5%W-W|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|20 TAMBORES DE 25 KG NET C-U|LOTE:LANS850170621 MFG DATE:06-2021 EXP DATE:05-2024 | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - PRINCIPIO:LANSOPRAZOL|USO: MEDICAMENTO PARA USO HUMANO - LOTE: C02405A F. EXPIRA:4.2024|LANSOPRAZOL 30MG CAPCR BL7 M24 PE-LANSOPRAZOL 30MG|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 4934 | |||
30049099 | CAPSULES >> LANSOPRAZOLE-30mg CAPSULES Batch No.CLZ-140105 MANUFACTURING :01-2014 Exp:12-2016 | India | Peru | 10656 | |||
30049034 | LANSOPRAZOLE >> PHARMA DRG.& MED.LAN 30CON:LANSOPRAZOLEUSP 30 MGPACK:898X5X10C ; 30CON:LANSOPRAZOLE USP | India | Peru | 898 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|PRESENT.:CAJA X 7 CAPSULAS - PRODUCTO FARMACEUTICO|USO: MEDICAMENTO PARA USO HUMANO - PRINCIPIO:LANSOPRAZOL|LANSOPRAZOL 30MG CJX7 CAP-PE|743292 - GP15139 - LOTE:D01493A VCTO:12-2024 - REGISTRO SANITARIO:EE-00699 | Colombia | Peru | 6299 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|USO: MEDICAMENTO PARA USO HUMANO|LOTE:D01284D F.VCTO:11-2024|LANSOPRAZOL 30MG CJX7 CAP-PE - PRESENTACION: CAJA X 7 CAPSULAS|743292 - GP15139 | Colombia | Peru | 5238 | |||
2933399000 | LANSOPRAZOLE , SIGMA ALDRICH , S-M|PHR1390-1G|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 1G|ESTANDAR DE LANSOPRAZOL , BATCH: LRAD2346 | China | Peru | 1 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00586 , VENCE: 30-04-2025|LANSOPRAZOL 30MG | Argentina | Peru | 7951 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R07130|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A (25MG) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|BATCH: D556 - MFG.DT. 04.2023 - EXP.DT. 10.2025|MEDICAMENTO DE USO HUMANO|LANSOPRAZOL 30MG - LANSOPRAZOL|LANSOPRAZOL 30MG CAPSULA BLANDA DE LIBERACION RETARDADA - CAJA *10 , TRANSFRENCIA BANCARIA N | India | Peru | 5200 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS LOTE: D00772D F. EXPIRA.09-2024|MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG CJX7 CAP-PE|743292- GP15139- REGISTRO SANITARIO: EE-00699 | Colombia | Peru | 4982 | |||
30049099 | LANSOPRAZOL 30MG LANSOPRAZOLE CAPSULES30MG B/NO.D556, M/DT.04/2023,E/DT.10/20255200X10X10 | India | Peru | 5200 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - PRINCIPIO:LANSOPRAZOL|USO: MEDICAMENTO PARA USO HUMANO - LOTE: D00470C F. EXPIRA:07.2024|LANSOPRAZOL 30MG CAJA X 7 CAPSULAS|743292 , GP15139 - RS: EE-00699 DEL 06-08-2019 - 06-08-2024 | Colombia | Peru | 10453 | |||
2933399000 | LANSOPRAZOLE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1356916|LANSOPRAZOLE (150 MG) | India | Peru | 3 | |||
2933199000 | LANSOPRAZOLE PELLETS , S-M , S-M|LANSOPRAZOLE PELLETS ¿ 8.5% W-W 20 HDPE DRUMS (25 KGS NET EACH ) |EN LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS|BATCH N° : LANS850601122-FECHA MANUFACTURA:NOVIEMBRE 2022-FECHA EXPIRACION: OCTUBRE 2025 | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS - PRINCIPIO:LANSOPRAZOL|USO: MEDICAMENTO PARA USO HUMANO - LOTE: C02531A F. EXPIRA:05.2024|LANSOPRAZOL 30MG CAPCR BL7 M24 PE-LANSOPRAZOL 30MG|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 4921 | |||
2933399000 | LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|LANSOPRAZOL COMPUESTO RELACIONADO A (25 MG) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00334-SP|CAT: 1356927 , LOTE: R07130 | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R14880|ITEM: 1356916|LANSOPRAZOLE (150 MG) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R07130|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ( ( (3-METHYL-4 (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDIL) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH: LANS850591122 , MFG. DATE: NOV-2022; EXP. DATE: OCT-2025|IMSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5% W-W|EN 20 DRUMS CON 25KGS C-U | India | Peru | 500 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS -LOTE:C01991A F.V:3.2024|MEDICAMENTO PARA USO HUMANO|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 4956 | |||
2933399000 | LANSOPRAZOLE , SIGMA ALDRICH , S-M|PHR1390-1G|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 2 X 1G|ESTANDAR DE LANSOPRAZOL , BATCH: LRAD0184 | China | Peru | 2 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00572 , VENCE: 30-09-2024|LANSOPRAZOL 30MG | Argentina | Peru | 9955 | |||
3004902900 | LANSOPRAZOL 15 MG , S-M , S-M|ANTIULCEROSO - CONCENTRACION: 15 MG. - FORMA FARMACEUTICA: CAPSULAS|DONACION|FRASCO X 30 CAPSULAS. CAJA X 47 FRASCOS - CODIGO:422483|LOTE: 3137240 - FECHA DE VENCIMIENTO: 31-05-2023 | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 15 MG , S-M , S-M|ANTIULCEROSO - CONCENTRACION: 15 MG. - FORMA FARMACEUTICA: CAPSULAS|DONACION|FRASCO X 30 CAPSULAS. CAJA X 48 FRASCOS - CODIGO:422366|LOTE: 3137240 - FECHA DE VENCIMIENTO: 31-05-2023 | India | Peru | 5 | |||
3004902900 | LAN-30 LAN S-M|LOTE: M2205670 , MFG: 02-2022 , EXP: 01-2025 , LOTE: M2206964 , MFG: 04-2022 , EXP: 03-2025|INHIBIDOR DE LA BOMBA DE PROTONES - PROTECTOR GASTRICO - MEDICAMENTOS PARA USO HUMANO|3980 X 5 X 10 C|LANSOPRAZOL 30MG CAPSULA DE LIBERACION RETARDADA | India | Peru | 3980 | |||
2933399000 | LANSOPRAZOLE RELATED , SIGMA ALDRICH , S-M|PHR3019-50MG|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 50MG|COMPOUND A , BATCH: LRAC7161|N OPERACIÓN: 28269983 | China | Peru | 1 | |||
2933399000 | LANSOPRAZOLE RELATED , SIGMA ALDRICH , S-M|PHR3019-50MG|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 50MG|COMPOUND A , BATCH: LRAC7161|N OPERACIÓN: 28270350 | China | Peru | 1 | |||
2933399000 | LANSOPRAZOLE RELATED , SIGMA ALDRICH , S-M|PHR3019-50MG|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 50MG|COMPOUND A , BATCH: LRAC7161|N OPERACIÓN: 28269997 | China | Peru | 1 | |||
3004902900 | HELIGO (KIT PARA H. PILORI) HELIGO S-M|ANTIINFECCIOSO DE HELICOBACTER PILORI|MEDICAMENTO DE USO HUMANO|LANSOPRAZOL 30MG - TINIDAZOL 500MG - CLARITROMICINA 250 MG TABLETA|LOTE: M2211639 , MFG: 04-2022 , EXP: 03-2025 | India | Peru | 1748 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO- LOTE: C01437A 01-2024|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 3833 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO- LOTE: C01170A 12-2023|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 3552 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R07130|ITEM: 1356927|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ( ( (3-METHYL-4 (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDIL) |REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | LANSOPRAZOL 30 MG TABLETA , MYLAN , S-M|CAJA X 18 PAQUETES - CONCENTRACION: 30 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420906|LOTE: 3132608 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 36 | |||
3004902900 | LANSOPRAZOL 30 MG TABLETA , MYLAN , S-M|CAJA X 18 PAQUETES - CONCENTRACION: 30 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420907|LOTE: 3132607 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 36 | |||
3004902900 | LANSOPRAZOL 15 MG TABLETA , MYLAN , S-M|CAJA X 2 PAQUETES - CONCENTRACION: 15 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420765|LOTE: 3132605 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 1 | |||
3004902900 | LANSOPRAZOL 15 MG TABLETA , MYLAN , S-M|CAJA X 48 PAQUETES - CONCENTRACION: 15 MG - FORMA FARMACEUTICA: TABLETAS|DONACION|PAQUETE X 100 TABLETAS - CODIGO: 420761|LOTE: 3132605 , FECHA DE VENCIMIENTO: 31-03-2023 | United States | Peru | 8 | |||
2933199000 | LANSOPRAZOLE , S-M , S-M|BATCH: LANS850260622 , MFG. DATE: JUNE-2022; EXP. DATE: MAY-2025|IMSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5% W-W|EN 40 DRUMS CON 25 KGS C-U | India | Peru | 1000 | |||
3003901000 | LANSOPRAZOL PELLETS S-M S-M|LOTE LAN-P-2-2022020036 , FEC. FAB 02-2022 - F. EXP. 01-2025|REACTIVO DE REFERENCIA PARA ANALISIS DE INSUMOS FARMACEUTICOS|LANZOPRAZOL|LANSOPRAZOL PELLETS | India | Peru | 100 | |||
30049034 | PHRMA DRG&MED:LAN-30 LANSOPRAZOLE DELYED | India | Peru | 199000 | |||
3822900000 | LANSOPRAZOL COMPUESTO RELACIONADO A , U.S PHARMACOPEIAL , S-M|LANSOPRAZOL COMPUESTO RELACIONADO A (VIAL X 25 MG) |EST¦NDAR DE REFERENCIA CERTIFICADOS PARA PRUEBAS DE LABORATORIO|LANSOPRAZOLE RELATED COMPOUND A (25 MG) |CONTROL DE CALIDAD | India | Peru | 1 | |||
2933399000 | LANSOPRAZOL COMPUESTO RELACIONADO B , USP , S-M|LANSOPRAZOL COMPUESTO RELACIONADO B (25 MG) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00335-SP|1356931 | China | Peru | 2 | |||
2933399000 | LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|LANSOPRAZOL COMPUESTO RELACIONADO A (25 MG) |ESTANDAR DE REFERENCIA PARA PRUEBAS DE LABORATORIO|VP-00334-SP|1356927 | India | Peru | 2 | |||
2933199000 | LANSOPRAZOL PELLETS 8.5% S-M S-M|LANSOPRAZOLE PELLETS 8.5% 20 DRUMS|INSUMOS PARA INDUSTRIA FARMACEUTICA|LOTE: LANS850100322 MFG:03-2022 EXP:02-2025|LANSOPRAZOL PELLETS 8.5% | India | Peru | 500 | |||
2933199000 | LANSOPRAZOL PELLETS 8.5% S-M S-M|LANSOPRAZOLE PELLETS 8.5% 3 DRUMS|INSUMOS PARA LA INDUSTRIA FARMACEUTICA|LOTE: LANS850100322 MFG:03-2022 EXP: 02-2025|LANSOPRAZOL PELLETS 8.5% | India | Peru | 75 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO- LOTE: C00771C F.EXP.: 10.2023|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 - RS: EE- 00699 | Colombia | Peru | 3703 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO -RS: EE- 00699|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 , LOTE: C00624C F.EXP.: 09.2023 | Colombia | Peru | 8672 | |||
3004902900 | LANSOPRAZOL 30MG , S-M , S-M|CAJA X 7 CAPSULAS|MEDICAMENTO PARA USO HUMANO -RS: EE- 00699|LANSOPRAZOL 30MG CAPCR BL7 M24 PE|PAN00743292 , LOTE: C00624C F.EXP.: 09.2023 | Colombia | Peru | 8672 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00559 , VENCE: 30-04-2024|LANSOPRAZOL 30MG | Argentina | Peru | 10151 | |||
3004902900 | PRAZOLEX 30MG , SIEGFRIED , S-M|CAJA X 30 CAPSULAS|MEDICAMENTO DE USO HUMANO|CAPSULAS GASTRORRESISTENTES , 000002044808 , LOTE: 00559 , VENCE: 30-04-2024|LANSOPRAZOL 30MG | Argentina | Peru | 10151 | |||
2933399000 | LANSOPRAZOL PELLETS 8.5% , S-M , S-M|BATCH N° LANS850040222|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5%|MFG DATE: FEB-2022 - EXP DATE: JAN-2025 | India | Peru | 150 | |||
2933399000 | LANSOPRAZOL PELLETS 8.5% , S-M , S-M|BATCH N° LANS850040222|INSUMO PARA LA INDUSTRIA FARMACEUTICA|LANSOPRAZOLE PELLETS 8.5%|MFG DATE: FEB-2022 - EXP DATE: JAN-2025 | India | Peru | 150 | |||
3822900000 | E1 LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|E1 LANSOPRAZOL COMPUESTO RELACIONADO A|AN-LISIS QU-MICO.|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ({[3-METHYL-4- (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDYL|1356927 | India | Peru | 25 | |||
3822900000 | E1 LANSOPRAZOL COMPUESTO RELACIONADO A , USP , S-M|E1 LANSOPRAZOL COMPUESTO RELACIONADO A|AN-LISIS QU-MICO.|LANSOPRAZOLE RELATED COMPOUND A (25 MG) (2- ({[3-METHYL-4- (2 , 2 , 2-TRIFLUOROETHOXY) -2-PYRIDYL|1356927 | India | Peru | 25 |
Volza's data of Peru Lansoprazole imports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of Peru Lansoprazole imports helps you create a import strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find Peru Lansoprazole import market intelligence of last 10 years with buyer, supplier, price and volume from Volza.com
You can find New markets for Lansoprazole imports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Major products related with Lansoprazole are Rilpivirine, Amphotericin B, L Arginine Monohydrochloride, Azithromycin, Propranolol Hydrochloride.
Top 5 HSN codes for Lansoprazole are HSN Code 3004902900 , HSN Code 2933399000, HSN Code 3003901000, HSN Code 3822009000, HSN Code 30049034, You can check for details at https://www.volza.com/hs-codes.
Volza's data of Peru Lansoprazole imports is 100% authentic as it is based on actual import export shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of Peru Lansoprazole imports contains strategic information and is very useful for importers and exporters who want to expand global trade, improve supply chain of Lansoprazole, find economical vendors, new buyers and fast growing markets.
Data of Peru Lansoprazole imports contains date of shipment, Name and contact details of importer, exporter, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of Peru Lansoprazole imports every month.
You can download latest data of Dec-2023 of Peru Lansoprazole imports here
You can download Volza Peru Lansoprazole import data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners